XML 55 R33.htm IDEA: XBRL DOCUMENT ﻿
v2.3.0.11

Segment information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2011
Financial Information Relating to Operating Segments | Following is financial information relating to the operating segments (in thousands):
|  | Year Ended June 30, |
|  | 2011 |  |  | 2010 |  |  | 2009 |
External sales |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 270,287 |  |  | $ | 250,653 |  |  | $ | 246,454 |
Hematology |  |  | 19,675 |  |  |  | 18,394 |  |  |  | 17,502 |
Consolidated net sales |  | $ | 289,962 |  |  | $ | 269,047 |  |  | $ | 263,956 |
Earnings before taxes |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 164,332 |  |  | $ | 155,989 |  |  | $ | 156,039 |
Hematology |  |  | 7,222 |  |  |  | 6,869 |  |  |  | 6,143 |
Segment earnings before taxes |  |  | 171,554 |  |  |  | 162,858 |  |  |  | 162,182 |
Other |  |  | (6,573 | ) |  |  | (6,412 | ) |  |  | (6,819 | )
Consolidated earnings before taxes |  | $ | 164,981 |  |  | $ | 156,446 |  |  | $ | 155,363 |
Goodwill |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 86,633 |  |  | $ | 25,068 |  |  | $ | 25,068 |
Hematology |  |  | 0 |  |  |  | 0 |  |  |  | 0 |
Consolidated goodwill |  | $ | 86,633 |  |  | $ | 25,068 |  |  | $ | 25,068 |
Intangible assets, net |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 52,282 |  |  | $ | 2,044 |  |  | $ | 3,004 |
Hematology |  |  | 0 |  |  |  | 0 |  |  |  | 0 |
Consolidated intangible assets, net |  | $ | 52,282 |  |  | $ | 2,044 |  |  | $ | 3,004 |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 505,087 |  |  | $ | 400,112 |  |  | $ | 355,445 |
Hematology |  |  | 21,046 |  |  |  | 18,543 |  |  |  | 15,804 |
Segment assets |  |  | 526,133 |  |  |  | 418,655 |  |  |  | 371,249 |
Other |  |  | 91,537 |  |  |  | 100,161 |  |  |  | 100,756 |
Consolidated assets |  | $ | 617,670 |  |  | $ | 518,816 |  |  | $ | 472,005 |
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 7,165 |  |  | $ | 5,411 |  |  | $ | 4,502 |
Hematology |  |  | 417 |  |  |  | 340 |  |  |  | 229 |
Segment depreciation and amortization |  |  | 7,582 |  |  |  | 5,751 |  |  |  | 4,731 |
Other |  |  | 1,118 |  |  |  | 2,379 |  |  |  | 3,035 |
Consolidated depreciation and amortization |  | $ | 8,700 |  |  | $ | 8,130 |  |  | $ | 7,766 |
Capital purchases |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | 2,707 |  |  | $ | 3,885 |  |  | $ | 3,501 |
Hematology |  |  | 149 |  |  |  | 208 |  |  |  | 94 |
Segment capital purchases |  |  | 2,856 |  |  |  | 4,093 |  |  |  | 3,595 |
Other |  |  | 774 |  |  |  | 551 |  |  |  | 2,961 |
Consolidated capital purchases |  | $ | 3,630 |  |  | $ | 4,644 |  |  | $ | 6,556 |
Financial Information Relating to Geographic Areas | Following is financial information relating to geographic areas (in thousands):
|  | Year Ended June 30, |
|  | 2011 |  |  | 2010 |  |  | 2009 |
External sales |  |  |  |  |  |  |  |  |  |  |  |
United States |  | $ | 159,857 |  |  | $ | 148,137 |  |  | $ | 147,271 |
Europe |  |  | 83,676 |  |  |  | 78,496 |  |  |  | 79,381 |
China |  |  | 8,299 |  |  |  | 6,792 |  |  |  | 5,645 |
Other |  |  | 38,130 |  |  |  | 35,622 |  |  |  | 31,659 |
Total external sales |  | $ | 289,962 |  |  | $ | 269,047 |  |  | $ | 263,956 |
Long-lived assets |  |  |  |  |  |  |  |  |  |  |  |
United States |  | $ | 88,802 |  |  | $ | 91,554 |  |  | $ | 93,571 |
Europe |  |  | 7,819 |  |  |  | 6,299 |  |  |  | 7,214 |
China |  |  | 96 |  |  |  | 70 |  |  |  | 98 |
Total long-lived assets |  | $ | 96,717 |  |  | $ | 97,923 |  |  | $ | 100,883 |

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 38 -Subparagraph b(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 27, 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration